ESR1 and cancer: Triple-negative breast cancers (TNBC) are malignant tumors characterized by a lack of estrogen receptor (ER) and progesterone receptor (PR) expression and human epidermal growth factor receptor 2 (HER2)/neu overexpression [1,2].